Baird Medical Investment (BDMD) Competitors $4.31 -0.04 (-0.92%) As of 06/12/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BDMD vs. ICAD, ZJYL, PTHL, MGRM, MBOT, FONR, NTRB, SRTS, INO, and TELAShould you be buying Baird Medical Investment stock or one of its competitors? The main competitors of Baird Medical Investment include iCAD (ICAD), Jin Medical International (ZJYL), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Monogram Orthopaedics (MGRM), Microbot Medical (MBOT), FONAR (FONR), Nutriband (NTRB), Sensus Healthcare (SRTS), Inovio Pharmaceuticals (INO), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry. Baird Medical Investment vs. Its Competitors iCAD Jin Medical International Pheton Holdings Ltd Class A Ordinary Shares Monogram Orthopaedics Microbot Medical FONAR Nutriband Sensus Healthcare Inovio Pharmaceuticals TELA Bio Baird Medical Investment (NASDAQ:BDMD) and iCAD (NASDAQ:ICAD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, community ranking, earnings and risk. Is BDMD or ICAD more profitable? Baird Medical Investment has a net margin of 0.00% compared to iCAD's net margin of -17.81%. Baird Medical Investment's return on equity of 0.00% beat iCAD's return on equity.Company Net Margins Return on Equity Return on Assets Baird Medical InvestmentN/A N/A N/A iCAD -17.81%-15.65%-12.52% Do analysts rate BDMD or ICAD? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00iCAD 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders & institutionals have more ownership in BDMD or ICAD? 19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 24.6% of iCAD shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 10.3% of iCAD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, BDMD or ICAD? Baird Medical Investment has a beta of -0.92, suggesting that its stock price is 192% less volatile than the S&P 500. Comparatively, iCAD has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Does the media refer more to BDMD or ICAD? In the previous week, iCAD had 2 more articles in the media than Baird Medical Investment. MarketBeat recorded 4 mentions for iCAD and 2 mentions for Baird Medical Investment. iCAD's average media sentiment score of 1.43 beat Baird Medical Investment's score of 0.93 indicating that iCAD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iCAD 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer BDMD or ICAD? iCAD received 228 more outperform votes than Baird Medical Investment when rated by MarketBeat users. Likewise, 59.84% of users gave iCAD an outperform vote while only 0.00% of users gave Baird Medical Investment an outperform vote. CompanyUnderperformOutperformBaird Medical InvestmentOutperform VotesNo VotesUnderperform Votes2100.00% iCADOutperform Votes22859.84% Underperform Votes15340.16% Which has higher valuation and earnings, BDMD or ICAD? Baird Medical Investment has higher revenue and earnings than iCAD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBaird Medical Investment$37.04M0.77N/AN/AN/AiCAD$19.53M5.29-$4.85M-$0.19-19.79 SummaryiCAD beats Baird Medical Investment on 8 of the 13 factors compared between the two stocks. Get Baird Medical Investment News Delivered to You Automatically Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDMD vs. The Competition Export to ExcelMetricBaird Medical InvestmentSurgical, Medical, And Dental Instruments And Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.38M$335.89M$5.61B$8.62BDividend YieldN/AN/A5.28%4.17%P/E RatioN/AN/A27.2119.96Price / Sales0.7710.16408.49157.63Price / CashN/AN/A38.2534.64Price / BookN/AN/A7.074.69Net IncomeN/AN/A$3.23B$248.14M7 Day Performance-4.01%0.29%0.68%0.91%1 Month Performance-15.49%-0.41%9.59%5.71%1 Year PerformanceN/A243.25%32.02%14.71% Baird Medical Investment Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDMDBaird Medical InvestmentN/A$4.31-0.9%N/AN/A$28.38M$37.04M0.00N/AGap DownICADiCAD1.063 of 5 stars$3.92+0.5%N/A+144.2%$107.69M$19.53M-30.15140Positive NewsShort Interest ↓ZJYLJin Medical InternationalN/A$0.68-11.5%N/A-73.7%$106.61M$23.50M0.00245Short Interest ↓Gap UpHigh Trading VolumePTHLPheton Holdings Ltd Class A Ordinary SharesN/A$15.00+11.1%N/AN/A$98.73M$448.20K0.0011High Trading VolumeMGRMMonogram Orthopaedics2.9578 of 5 stars$2.63+3.5%$5.40+105.3%+24.6%$93.86M$365.00K-5.6028Positive NewsMBOTMicrobot Medical2.1526 of 5 stars$2.49-11.4%$9.00+261.4%+127.5%$90.58MN/A-3.1120News CoverageAnalyst RevisionGap DownHigh Trading VolumeFONRFONAR1.3345 of 5 stars$14.38-0.7%N/A-6.5%$89.20M$103.02M12.50480News CoveragePositive NewsShort Interest ↑NTRBNutriband2.3239 of 5 stars$7.79+1.2%$13.00+66.9%+25.2%$86.89M$2.40M-10.9710Gap UpSRTSSensus Healthcare2.5243 of 5 stars$5.00+1.6%$11.67+133.3%-8.8%$82.23M$39.49M12.5040Positive NewsINOInovio Pharmaceuticals4.0918 of 5 stars$2.22-2.2%$9.75+339.2%-78.1%$81.42M$283.10K-0.70320Positive NewsTELATELA Bio2.4843 of 5 stars$1.86-1.6%$7.25+289.8%-67.1%$73.57M$71.22M-1.10120 Related Companies and Tools Related Companies ICAD Competitors ZJYL Competitors PTHL Competitors MGRM Competitors MBOT Competitors FONR Competitors NTRB Competitors SRTS Competitors INO Competitors TELA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDMD) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baird Medical Investment Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Baird Medical Investment With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
